Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Longevity Health Holdings, Inc.CTCX · Entity 8659 | Director | October 11, 2024 | November 08, 2024 |
| Rein Therapeutics, Inc.ALRN · Entity 7071 | SVP, Chief Business Officer | January 31, 2020 | February 04, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Longevity Health Holdings, Inc.
Report date October 11, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2034-10-11 | Direct | 76,878 |
Reported balance
After 2024-10-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-10-11 · Grant · Acquired 76,878 · Balance 76,878 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.27 · Expires 2030-07-17 | Direct | 9,161 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 9,161 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.27 · Expires 2031-02-10 | Direct | 6,154 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 6,154 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.11 · Expires 2031-09-23 | Direct | 61,563 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 61,563 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy Carmell Insiders LLC | 22,500 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 22,500 F2: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
F2: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC.
Rein Therapeutics, Inc.
Report date January 31, 2020 · Filed February 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.67 · Expires 2030-01-30 | Direct | 185,000 |
Reported balance
After 2020-01-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-31 · Grant · Acquired 185,000 · Balance 185,000 F1: This option was granted on January 31, 2020. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 31, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on January 31, 2020. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 31, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2024 Filed Nov 8, 2024 17:00 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 76,878 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950170-24-124216 · ownership.xml · derivative · entry 2 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,878 Underlying: Common Stock · 76,878 shares Expires 2034-10-11 F1 · derivative.exercise_date: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,260 | $0.51 | $642.60 |
DisclosureSEC source: 0000950170-24-105169 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 22,500 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 18:26 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 109 | $0.57 | $62.13 |
DisclosureSEC source: 0000950170-24-103547 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 21,240 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 652 | $0.56 | $365.12 |
DisclosureSEC source: 0000950170-24-102373 · ownership.xml · nonDerivative · entry 2 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 21,131 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,084 | $0.56 | $607.04 |
DisclosureSEC source: 0000950170-24-102373 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 20,479 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 27, 2024 Filed Aug 29, 2024 17:19 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,413 | $0.71 | $1,713.23 |
DisclosureSEC source: 0000950170-24-101949 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 19,395 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 26, 2024 Filed Aug 26, 2024 19:58 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,413 | $0.72 | $1,737.36 |
DisclosureSEC source: 0000950170-24-100723 · ownership.xml · nonDerivative · entry 2 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 16,981 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 19:58 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,413 | $0.72 | $1,737.36 |
DisclosureSEC source: 0000950170-24-100723 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 14,568 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 17:08 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,413 | $0.72 | $1,737.36 |
DisclosureSEC source: 0000950170-24-100251 · ownership.xml · nonDerivative · entry 2 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 12,156 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 17:08 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 3,016 | $0.79 | $2,388.67 |
DisclosureSEC source: 0000950170-24-100251 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 9,743 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 17:10 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 739 | $3.94 | $2,908.04 |
DisclosureSEC source: 0000950170-23-071163 · ownership.xml · nonDerivative · entry 2 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 6,727 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 17:10 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 391 | $3.61 | $1,412.25 |
DisclosureSEC source: 0000950170-23-071163 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 5,988 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 13, 2023 Filed Dec 13, 2023 21:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,087 | $5.57 | $6,056.00 |
DisclosureSEC source: 0000950170-23-070166 · ownership.xml · nonDerivative · entry 3 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 5,597 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,087 | $3.50 | $3,806.24 |
DisclosureSEC source: 0000950170-23-070166 · ownership.xml · nonDerivative · entry 2 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 4,510 F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 21:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,087 | $3.53 | $3,833.96 |
DisclosureSEC source: 0000950170-23-070166 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 3,423 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 21:14 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-069161 · ownership.xml · nonDerivative · entry 6 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,415 F4 · balance_after: The shares beneficially owned by the Reporting Person include 48,415 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 8, 2023. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 21:14 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 46 | $3.15 | $144.90 |
DisclosureSEC source: 0000950170-23-069161 · ownership.xml · nonDerivative · entry 5 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 2,336 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 21:14 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 248 | $3.07 | $760.32 |
DisclosureSEC source: 0000950170-23-069161 · ownership.xml · nonDerivative · entry 4 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 2,290 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.01 to $3.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 21:14 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 608 | $3.03 | $1,844.00 |
DisclosureSEC source: 0000950170-23-069161 · ownership.xml · nonDerivative · entry 3 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 2,042 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.99 to $3.054, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 05, 2023 Filed Dec 8, 2023 21:14 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 347 | $3.10 | $1,077.37 |
DisclosureSEC source: 0000950170-23-069161 · ownership.xml · nonDerivative · entry 2 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 1,434 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 04, 2023 Filed Dec 8, 2023 21:14 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,087 | $3.00 | $3,259.26 |
DisclosureSEC source: 0000950170-23-069161 · ownership.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 1,087 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:41 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 61,563 | Not disclosed Strike: $2.11 | Not disclosed |
DisclosureSEC source: 0001062993-23-015062 · form4.xml · derivative · entry 3 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,563 Underlying: Common Stock · 61,563 shares Expires 2031-09-23 F4 · price: On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation. F3 · derivative.exercise_date: Options to purchase 61,563 shares of common stock of Legacy Carmell granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2023 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:41 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 6,154 | Not disclosed Strike: $2.27 | Not disclosed |
DisclosureSEC source: 0001062993-23-015062 · form4.xml · derivative · entry 2 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,154 Underlying: Common Stock · 6,154 shares Expires 2031-02-10 F4 · price: On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation. F2 · derivative.exercise_date: Options to purchase 6,154 shares of common stock of Legacy Carmell granted on February 10, 2021, which vest as follows: 25% vested on February 10, 2022 and February 10, 2023 and the remaining 50% becomes vested in 24 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:41 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 9,161 | Not disclosed Strike: $2.27 | Not disclosed |
DisclosureSEC source: 0001062993-23-015062 · form4.xml · derivative · entry 1 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,161 Underlying: Common Stock · 9,161 shares Expires 2030-07-17 F4 · price: On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation. F1 · derivative.exercise_date: Options to purchase 9,161 shares of common stock of Legacy Carmell (as defined below) granted on July 17, 2020, which vest as follows: 25% vested on July 17, 2021, July 17, 2022 and July 17, 2023 and the remaining 25% becomes vested in 12 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| September 23, 2021 Filed Dec 13, 2023 21:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-070166 · ownership.xml · nonDerivative · entry 4 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,543 F4 · balance_after: The shares beneficially owned by the Reporting Person consist of 48,543 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 13, 2023. Read SEC document |
| September 23, 2021 Filed Dec 18, 2023 17:10 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-071163 · ownership.xml · nonDerivative · entry 3 Gregory Kathryn · CIK 0001768530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,385 F4 · kind: The shares beneficially owned by the Reporting Person include 48,734 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023. F4 · balance_after: The shares beneficially owned by the Reporting Person include 48,734 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:30 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | GrantStock Option (right to buy) · Derivative | 185,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0000899243-20-002804 · doc4.xml · derivative · entry 1 Gregory Kathryn · CIK 0001768530 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2030-01-30 F1 · derivative.exercise_date: This option was granted on January 31, 2020. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 31, 2020. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:16 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | PurchaseCommon Stock | 45,000 | $0.65 | $29,025.00 |
DisclosureSEC source: 0000899243-19-021791 · doc4.xml · nonDerivative · entry 1 Gregory Kathryn · CIK 0001768530 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 22:40 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0000899243-19-010811 · doc4.xml · derivative · entry 1 Gregory Kathryn · CIK 0001768530 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-04-14 F1 · derivative.exercise_date: This option was granted on April 15, 2019. The shares underlying the option are scheduled to vest in equal monthly installments over four years from April 15, 2019. Read SEC document |
| February 25, 2019 Filed Feb 25, 2019 22:51 UTC | Rein Therapeutics, Inc. ALRN · Entity 7071 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0000899243-19-004732 · doc4.xml · derivative · entry 1 Gregory Kathryn · CIK 0001768530 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-02-24 F1 · derivative.exercise_date: This option was granted on February 25, 2019. The shares underlying the option are scheduled to vest as to 25% of the shares on February 25, 2020 and thereafter in equal monthly installments through February 25, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.